Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The British Thoracic Society survey of rehabilitation to support recovery of the Post Covid-19 population

View ORCID ProfileSJ Singh, View ORCID ProfileA Barradell, View ORCID ProfileN Greening, View ORCID ProfileCE Bolton, View ORCID ProfileG Jenkins, L Preston, View ORCID ProfileJR Hurst
doi: https://doi.org/10.1101/2020.05.07.20094151
SJ Singh
1Department of Respiratory Sciences, University of Leicester, Leicester, UK
2Centre for Exercise and Rehabilitation Science, NIHR Leicester Biomedical Research Centre–Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for SJ Singh
  • For correspondence: sally.singh@uhl-tr.nhs.uk
A Barradell
1Department of Respiratory Sciences, University of Leicester, Leicester, UK
2Centre for Exercise and Rehabilitation Science, NIHR Leicester Biomedical Research Centre–Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Barradell
N Greening
1Department of Respiratory Sciences, University of Leicester, Leicester, UK
2Centre for Exercise and Rehabilitation Science, NIHR Leicester Biomedical Research Centre–Respiratory, University Hospitals of Leicester NHS Trust, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N Greening
CE Bolton
3NIHR Nottingham Biomedical Research Centre Respiratory theme, School of Medicine, University of Nottingham. Nottingham. UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for CE Bolton
G Jenkins
3NIHR Nottingham Biomedical Research Centre Respiratory theme, School of Medicine, University of Nottingham. Nottingham. UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G Jenkins
L Preston
4British Thoracic Society, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JR Hurst
5UCL Respiratory, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JR Hurst
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Those discharged from hospital after treatment for Covid-19 are likely to have significant and ongoing symptoms, functional impairment and psychological disturbances. There is an immediate need to develop a safe and efficient discharge process and recovery programme. Pulmonary rehabilitation is well placed to deliver a rehabilitation programme for this group but will most likely need to be adapted for the post Covid-19 population. The purpose of this survey was to rapidly identify the components of a post-Covid-19 rehabilitation assessment and elements of a successful rehabilitation programme that would be required to deliver a comprehensive service for those post Covid-19 to inform service delivery.

Design A survey comprising a series of closed questions and a free text comments box allowing for a qualitative analysis.

Setting Online survey.

Participants British Thoracic Society members and multi-professional clinicians, across specialities were invited to take part.

Results 1031 participants responded from a broad range of specialities over 6 days. There was overwhelming support for early post discharge from hospital phase of the recovery programme to advise patients about the management of fatigue (95% agreed/ strongly agreed), breathlessness (94%), and mood disturbances (including symptoms of anxiety and depression) 92%. At the 6-8-week time point an assessment was considered important, focusing on the assessment of a broad range of possible symptoms and the need to potentially return to work. Recommendations for the intervention described a holistic programme focusing on symptom management, return of function and return to employment. The free text comments added depth to the survey and the need ‘not to reinvent the wheel’ rather adapt well established (pulmonary rehabilitation) services to accommodate the needs of the post Covid-19 population.

Conclusion The responses indicate the huge interest and the urgent need establish a programme to support and mitigate the long term impact of Covid-19.

Strengths and limitations

  • Large and comprehensive survey conducted to guide the provision of post Covid-19 rehabilitation.

  • The survey provides clear recommendations for the provision of advice and support immediately upon discharge, and recommendations for a programme of holistic rehabilitation 6-8 weeks post discharge based upon the existing pulmonary rehabilitation model.

  • The survey engaged a wide range of specialities and experiences managing Covid-19

  • The opinions of patients and carers be sought in an additional survey

Funding statement This research received no specific grant funding from any funding agency in the public, commercial or not-for-profit sector.

Competing interests All authors have completed the Unified Competing Interests Form at http://www.icmie.org.coi_disclosure.pdf

Dr. Singh reports grants from Actegy, grants from Pfizer, outside the submitted work.

Dr. Jenkins reports grants from Astra Zeneca, grants from Biogen, personal fees from Boehringer Ingelheim, personal fees from Daewoong, personal fees from Galapagos, grants from Galecto, grants from GlaxoSmithKline, personal fees from Heptares, non-financial support from NuMedii, grants and personal fees from Pliant, personal fees from Promedior, non-financial support from Redx, personal fees from Roche, other from Action for Pulmonary Fibrosis, outside the submitted work.

Data sharing statement No additional data are available.

Competing Interest Statement

All authors have completed the Unified Competing Interests Form at http://www.icmje.org.coi_disclosure.pdf Dr. Singh reports grants from Actegy, grants from Pfizer, outside the submitted work. Dr. Jenkins reports grants from Astra Zeneca, grants from Biogen, personal fees from Boehringer Ingelheim, personal fees from Daewoong, personal fees from Galapagos, grants from Galecto, grants from GlaxoSmithKline, personal fees from Heptares, non-financial support from NuMedii, grants and personal fees from Pliant, personal fees from Promedior, non-financial support from Redx, personal fees from Roche, other from Action for Pulmonary Fibrosis, outside the submitted work.

Funding Statement

This research received no specific grant funding from any funding agency in the public, commercial or not-for-profit sector.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No additional data are available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The British Thoracic Society survey of rehabilitation to support recovery of the Post Covid-19 population
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The British Thoracic Society survey of rehabilitation to support recovery of the Post Covid-19 population
SJ Singh, A Barradell, N Greening, CE Bolton, G Jenkins, L Preston, JR Hurst
medRxiv 2020.05.07.20094151; doi: https://doi.org/10.1101/2020.05.07.20094151
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The British Thoracic Society survey of rehabilitation to support recovery of the Post Covid-19 population
SJ Singh, A Barradell, N Greening, CE Bolton, G Jenkins, L Preston, JR Hurst
medRxiv 2020.05.07.20094151; doi: https://doi.org/10.1101/2020.05.07.20094151

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Rehabilitation Medicine and Physical Therapy
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)